SEC Form EFFECT filed by Opiant Pharmaceuticals Inc.
$OPNT
Biotechnology: Pharmaceutical Preparations
Health Care
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 9, 2023 |
| Accession Number: | 0001385508-23-000095 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||